Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
FDA Warns of Deaths Tied to Tainted Synthetic PotWhere Are Opioid Painkillers Prescribed the Most?In the ICU, Patients' Relatives Often Mum About Care ConcernsResetting E-Prescriptions for Opioids Helps Curb Use: StudyHealth Tip: If You're 45 or Older, Get Screened for Colorectal CancerRed Cross Issues Nationwide Call for Blood DonationsDoctor Burnout Widespread, Helps Drive Many Medical ErrorsWarming Climate, More AC -- and More Unhealthy Smog AheadEven at 'Safe' Levels, Air Pollution May Boost Diabetes RiskDeath Certificate Data May Miss Many Opioid ODs: StudyRaise the Bar on CPR, Heart Group SaysWhen DEA Cracked Down on Opioids, Abusers Moved to Black Market: StudyStigma of Safe Needle Exchanges Lingers Despite Opioid EpidemicAHA: Drones a Lifesaver for Cardiac Arrest Patients?Millions Die Worldwide Each Year for Lack of Quality CareTips for Handling a Medical EmergencyAHA: Lifesaving Info Not Always a 911 Call AwayMany, But Not All, Hospitals Require Flu Shots for StaffersCancer Care Twice as Costly in U.S. Versus CanadaAHA: Health Concerns Haunt Puerto Rico as New Hurricane Season BeginsPot, Opioids Now Rival Alcohol as Factor in Driver DeathsThe ER or Urgent Care?Trumps Signs Bill Allowing Terminal Patients to Try Unproven MedicinesTough State Drunk Driving Laws Save LivesE-Cigarettes Don't Help Smokers Quit, But Cash MightSmall World? Not With One-Quarter Obese by 2045A Pill to Protect You From the Sun? Don't Believe It, FDA SaysMost Hospitals Aren't Ready for Mass Tragedies, ER Docs SayAHA: Making America's Doctors Look More Like AmericaLanguage Used in Medical Record Can Affect Patient CareNonprofit Manufacturer Could Keep Generic Drug Costs DownOpioid Makers' Perks to Docs Tied to More PrescriptionsFDA Targets Clinics Offering Unapproved Stem Cell TherapiesLittle 'Quit-Smoking' Help at U.S. Mental Health CentersIs Testing for Zika in U.S. Blood Supply Worth the Cost?'Smoke-Free' Rooms Still Loaded With Smoke Residues, Study FindsAHA: Smoke-Free Laws Do Seem to Help Young Adults' HeartsAHA: Poverty Levels Key to States' Performance on Heart DiseaseSimple Drug Packaging Change Could Save Toddlers' LivesFDA Cracks Down on Dangerous E-Cig Liquids That Resemble Cookies, CandyNew Clinic Satisfaction Tool Provides Real-Time FeedbackUnused Meds? Saturday Is National Drug Take Back DayA Doctor's Age May Matter With Emergency SurgeryPatients Prefer Doctors Who Engage in Face-to-Face VisitsU.S. Better Able to Tackle Health Emergencies: ReportFirst Opioid Lawsuit Targeting Pharmacy Benefit ManagersMost Doctors' Offices Don't Offer Flexibility for UninsuredSafety Info for Opioids Found LackingNonoptimized Drug Therapy Costs More Than $500 Billion AnnuallyFDA Cracks Down on Caffeine-Loaded Supplements
Questions and AnswersLinksBook Reviews
Related Topics

Monkey Deaths Prompt FDA Probe, New Controls on Animal Research

HealthDay News
by -- Robert Preidt
Updated: Jan 26th 2018

new article illustration

FRIDAY, Jan. 26, 2018 (HealthDay News) -- A U.S. government study using monkeys to investigate nicotine addiction has been halted and an investigation launched after four monkeys died.

In the wake of the deaths, the Food and Drug Administration said Friday that it is reviewing its rules on animal studies and has created a new council to oversee them.

The study at the FDA's National Center for Toxicological Research (NCTR) used squirrel monkeys to gauge how various levels of nicotine affect the risk of addiction in teens and young adults.

No new studies will begin at the NCTR until the investigation is complete, FDA Commissioner Dr. Scott Gottlieb said. The surviving monkeys will be placed in a permanent sanctuary home, he added.

"The FDA has a deep commitment to ensuring the responsible and humane care of animals when research involving animals is needed to fulfill the agency's public health mission. The FDA also is fully committed to complying with the rules and guidance governing animal research," Gottlieb said in a statement.

After learning about the monkey deaths and other concerns, Gottlieb said he immediately stopped the study. He also asked the FDA's Principal Deputy Commissioner to lead a review of the well-being of animals involved in the study and the circumstances surrounding the four deaths.

Gottlieb also ordered an independent, third-party probe of all of the FDA's animal research programs.

A new Animal Welfare Council will oversee all animal research studies and facilities under FDA control. It will advise the FDA on its approach to animal welfare and ensure animal studies meet the agency's standards, according to the statement.

The FDA will also "reaffirm and strengthen our commitment to replacing, reducing, and/or refining animal studies," Gottlieb said.

He added, however, that there remain many areas where animal research is important and necessary.

"We understand and share concerns that animals be involved in research only when there is no other way to fulfill an important public health objective. And, when these studies are necessary, the animals involved in research must be cared for under strict, humane guidelines," Gottlieb stated.

"I am committed to ensuring an effective, humane and judicious animal research program at FDA, and I will continue to communicate with our stakeholders on our efforts," he concluded.

More information

The Humane Society of the United States has more on the use of animals in research.